Type
Blood Testing
Biomarkers
1
Duration
30 min
Results
14 days
Sample
Blood draw
What's included
3 deliverables in this treatment
- Multiple tumor markers and/or liquid biopsy analysis
- Specific markers vary by provider and technology used
- Results report with risk assessment
Comprehensive annual health checkup for women over 60 including lung cancer screening. Extensive health assessment with advanced cancer detection technologies.
About this treatment
Multi-cancer screening uses blood-based biomarkers to screen for signs of multiple cancer types in a single test. These panels may include traditional tumor markers (PSA, CEA, CA-125, AFP), advanced liquid biopsy technology (circulating tumor DNA), or multi-analyte algorithms. The field of cancer early detection through blood testing is advancing rapidly, with new tests able to detect signals from dozens of cancer types — many of which have no standard screening method. While no blood test can definitively diagnose cancer on its own, abnormal results guide further investigation with imaging and biopsy. Early detection significantly improves treatment outcomes across nearly all cancer types.
Good to know
- Cancers Screened
- Multiple types (varies by panel)
- Fasting Required
- No (for most panels)
- Sample Type
- Blood draw
- Turnaround
- 1–3 weeks
- Important
- Screening tool — further evaluation needed for positive results
Who is this for?
Health-conscious individuals seeking proactive cancer screening. People over 50 or those with a family history of multiple cancer types. Anyone interested in the latest advances in cancer early detection technology. Those who want screening beyond what standard guidelines recommend.
Preparation required
Fasting for 10–12 hours before your appointment is recommended for accurate results (water is fine). Avoid alcohol for 24 hours and intense exercise for 12 hours before the blood draw. Morning appointments are ideal for consistent hormone and glucose readings. The blood draw typically takes 5–10 minutes.
Panel categories
Biomarkers tested
1A protein produced by prostate cells. Elevated PSA can indicate prostate cancer, but also benign prostate enlargement, prostatitis, or recent ejaculation. PSA velocity (rate of change) and PSA density add diagnostic value.
About the clinic
Reviews, team and credentials
Independent review links and clinic-reported team information.
5,234 clinic reviews
From independent platforms
Treatment highlights
- Multiple tumor markers and/or liquid biopsy analysis
- Specific markers vary by provider and technology used
+1 more item in What's included